Company intelligence / Profile preview

Ahren Innovation Capital

Cambridge, England, United Kingdom

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Ahren Innovation Capital is a leading science- and deep tech-focused investment firm, actively supporting companies across biotech, pharma, diagnostics, AI, and related sectors; numerous portfolio companies have entered significant clinical stages and commercial partnerships.

Therapeutic areas: OncologyImmunologyOther
Modalities: AntibodyProteinPeptidesSynthetic BiologySmall molecule
Industry: Investors

Partnerships

Strategic LP partnerships with large industry players (exact names undisclosed)Portfolio partnerships via investee companies (e.g., Constructive Bio partnerships with OMX Ventures, Paladin Capital Group)

Beyond the preview

Go deeper on Ahren Innovation Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ahren Innovation Capital.

Explore the full profile